To view this email as a web page, click here.
 
Trump considers next FDA commissioner
Finding a replacement for former FDA Commissioner Scott Gottlieb, MD, who resigned earlier this year, is proving to be controversial.
Read more
 
Lung cancer drug receives breakthrough therapy designation
Targeted therapy gives new hope to patients with an aggressive form of lung cancer.
Read more
 
New reimbursement may level playing field for biosimilars
From our sister publication, Managed Healthcare Executive: Even though new biosimilars could play a key role in increasing competition and reducing prices, access could be limited by several factors.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.